Literature DB >> 29486136

Non-traumatic neurological injury and hepatitis E infection.

Paolo Ripellino1, Benjamin Norton2, Jeroen van Eijk3, Harry R Dalton4.   

Abstract

Entities:  

Keywords:  Autochthonous; Guillain–Barré syndrome (GBS); hepatitis E virus (HEV); neuralgic amyotrophy (NA); neurological injury

Mesh：

Year:  2018        PMID： 29486136     DOI： 10.1080/14787210.2018.1446827

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  4 in total

1.  Herpes zoster increased risk of neuralgic amyotrophy: a retrospective, population-based matched cohort study.

Authors:  Tsung-Yen Ho; Chi-Hsiang Chung; Yu-Ping Shen; Liang-Cheng Chen; Wu-Chien Chien; Yung-Tsan Wu
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

2.  Neurologic complications of acute hepatitis E virus infection.

Authors:  Paolo Ripellino; Emanuela Pasi; Giorgia Melli; Claudio Staedler; Monserrat Fraga; Darius Moradpour; Roland Sahli; Vincent Aubert; Gladys Martinetti; Florian Bihl; Enos Bernasconi; Benedetta Terziroli Beretta-Piccoli; Andreas Cerny; Harry Roland Dalton; Cinzia Zehnder; Barbara Mathis; Chiara Zecca; Giulio Disanto; Alain Kaelin-Lang; Claudio Gobbi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-12-05

3.  HEV-Associated Neuralgic Amyotrophy: A Multicentric Case Series.

Authors:  Johannes H Bannasch; Benjamin Berger; Claus-Peter Schwartkop; Marco Berning; Oliver Goetze; Marcus Panning; Miriam Fritz-Weltin; George Trendelenburg; Mathias Gelderblom; Marc Lütgehetmann; Fridrike Stute; Thomas Horvatits; Meike Dirks; Christoph Antoni; Patrick Behrendt; Sven Pischke
Journal:  Pathogens       Date:  2021-05-30

4.  Hepatitis E virus as a trigger for Guillain-Barré syndrome.

Authors:  Miriam Fritz-Weltin; Estelle Frommherz; Nora Isenmann; Lisa Niedermeier; Benedikt Csernalabics; Tobias Boettler; Christoph Neumann-Haefelin; Dominique Endres; Marcus Panning; Benjamin Berger
Journal:  BMC Neurol       Date:  2021-08-06       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.